Supplementary Figure S4 from Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies | Synapse
February 22, 2024Open Access
Supplementary Figure S4 from Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies
Key Points
Key points are not available for this paper at this time.
Abstract
Enhanced phagocytosis in OCI-Ly3 cells is achieved when BMS-986351 is combined with rituximab.